Access the full text.
Sign up today, get DeepDyve free for 14 days.
H. Nazer, R. Ede, A. Mowat, R. Williams (1986)
Wilson's disease: clinical presentation and use of prognostic index.Gut, 27
N. Becker, Joel Rodriguez, N. Barshes, C. O'Mahony, J. Goss, T. Aloia (2007)
Outcomes Analysis for 280 Patients with Cholangiocarcinoma Treated with Liver Transplantation Over an 18-year PeriodJournal of Gastrointestinal Surgery, 12
J. Burton, J. O’Leary, E. Verna, V. Saxena, J. Dodge, R. Stravitz, J. Levitsky, J. Trotter, G. Everson, Robert Brown, N. Terrault (2014)
A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapy.Journal of hepatology, 61 3
Lior Katz, Lior Katz, Lior Katz, M. Paul, Daniel Guy, Ran Tur-Kaspa (2010)
Prevention of recurrent hepatitis B virus infection after liver transplantation: hepatitis B immunoglobulin, antiviral drugs, or both? Systematic review and meta‐analysisTransplant Infectious Disease, 12
H. El‐Serag, K. Rudolph (2007)
Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.Gastroenterology, 132 7
J. Carrión, M. Navasa, M. García-Retortillo, J. García‐Pagán, G. Crespo, M. Bruguera, J. Bosch, X. Forns (2007)
Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study.Gastroenterology, 132 5
G. Everson, Matthew Taylor, R. Doctor (2004)
Polycystic disease of the liverHepatology, 40
R. Robles, J. Figueras, V. Turrión, C. Margarit, Á. Moya, E. Varó, J. Calleja, A. Valdivieso, J. Valdecasas, P. López, Manuel Gómez, E. Vicente, C. Loinaz, J. Santoyo, M. Fleitas, A. Bernardos, L. Lladó, P. Ramírez, F. Bueno, E. Jaurrieta, P. Parrilla (2004)
Spanish Experience in Liver Transplantation for Hilar and Peripheral CholangiocarcinomaAnnals of Surgery, 239
A. Coilly, B. Roche, J. Dumortier, V. Leroy, D. Botta‐Fridlund, S. Radenne, G. Pageaux, S. Si-Ahmed, O. Guillaud, T. Antonini, S. Haïm-Boukobza, A. Roque-Afonso, D. Samuel, J. Duclos‐Vallée (2014)
Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: a multicenter experience.Journal of hepatology, 60 1
B. Roche, M. Sebagh, M. Canfora, T. Antonini, A. Roque-Afonso, V. Delvart, F. Saliba, J. Duclos‐Vallée, D. Castaing, D. Samuel (2008)
Hepatitis C virus therapy in liver transplant recipients: Response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosisLiver Transplantation, 14
L. Kikuchi, A. Chagas, R. Alencar, D. Paranaguá-Vezozzo, F. Carrilho (2013)
Clinical and Epidemiological Aspects of Hepatocellular Carcinoma in BrazilAntiviral Therapy, 18
Á. Herráiz, Rodrigo Torres-Quevedo, José Pallardó (2008)
Trasplante hepático en pacientes con lesiones hepáticas benignasCirugia Espanola, 84
R. Wiesner (1998)
Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: predicting outcomes with natural history models.Mayo Clinic proceedings, 73 6
Lisa Casey, William Lee (2013)
Hepatitis C virus therapy update 2013Current Opinion in Gastroenterology, 29
Y. Treut, E. Gregoire, J. Klempnauer, J. Belghiti, E. Jouve, J. Lerut, D. Castaing, O. Soubrane, O. Boillot, G. Mantion, K. Homayounfar, M. Bustamante, D. Azoulay, P. Wolf, M. Krawczyk, A. Pascher, B. Suc, L. Chiche, J. Urbina, V. Mejzlík, M. Pascual, J. Lodge, S. Gruttadauria, F. Paye, F. Pruvot, S. Thorban, A. Foss, R. Adam (2013)
Liver Transplantation for Neuroendocrine Tumors in Europe—Results and Trends in Patient Selection: A 213-Case European Liver Transplant Registry StudyAnnals of Surgery, 257
A. Gruessner, R. Gruessner (2016)
Pancreas Transplantation of US and Non-US Cases from 2005 to 2014 as Reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR).The review of diabetic studies : RDS, 13 1
L. Chiche, T. Dao, É. Salame, M. Galais, N. Bouvard, G. Schmutz, P. Rousselot, P. Bioulac-Sage, P. Ségol, M. Gignoux (2000)
Liver adenomatosis: reappraisal, diagnosis, and surgical management: eight new cases and review of the literature.Annals of surgery, 231 1
M. Charlton, A. Thompson, B. Veldt, K. Watt, H. Tillmann, J. Poterucha, J. Heimbach, D. Goldstein, J. McHutchison (2011)
Interleukin‐28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infectionHepatology, 53
A. Coilly, B. Roche, J. Duclos‐Vallée, D. Samuel (2014)
Management of HCV transplant patients with triple therapyLiver International, 34
M. Pavel, E. Baudin, A. Couvelard, E. Krenning, K. Öberg, T. Steinmüller, M. Anlauf, B. Wiedenmann, R. Salazar (2011)
ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown PrimaryNeuroendocrinology, 95
A. Coilly, M. Sebagh, J. Duclos‐Vallée (2014)
Reply to: "Frequent plasma cell hepatitis during telaprevir-based triple therapy for hepatitis C after liver transplantation".Journal of hepatology, 60 4
Â. Ferraz, M. Sette, M. Maia, E. Lopes, M. Godoy, A. Petribú, M. Meira, Otávio Borges (2004)
Liver transplant for the treatment of giant hepatic hemangiomaLiver Transplantation, 10
G. Ercolani, G. Grazi, A. Pinna (2010)
Liver Transplantation for Benign Hepatic Tumors: A Systematic ReviewDigestive Surgery, 27
A. Kirk, S. Jain, S. Pocock, H. Thomas, S. Sherlock (1980)
Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis.Gut, 21
G. Kirchner, K. Rifai, T. Cantz, B. Nashan, C. Terkamp, T. Becker, C. Strassburg, H. Barg‐Hock, S. Wagner, R. Lück, J. Klempnauer, M. Manns (2006)
Outcome and quality of life in patients with polycystic liver disease after liver or combined liver‐kidney transplantationLiver Transplantation, 12
M. Zimmerman, R. Ghobrial, M. Tong, J. Hiatt, A. Cameron, Johnny Hong, R. Busuttil (2008)
Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators.Archives of surgery, 143 2
J. Lerut, O. Ciccarelli, M. Rutgers, G. Orlando, Jules Mathijs, E. Danse, É. Goffin, J. Gigot, P. Goffette (2005)
Liver transplantation with preservation of the inferior vena cava in case of symptomatic adult polycystic diseaseTransplant International, 18
R. Gedaly, M. Daily, D. Davenport, P. McHugh, A. Koch, P. Angulo, J. Hundley (2011)
Liver transplantation for the treatment of liver metastases from neuroendocrine tumors: an analysis of the UNOS database.Archives of surgery, 146 8
Jin-yang Gu, J. Bai, Xiaolei Shi, Jian-xin Zhou, Y. Qiu, Ya-fu Wu, Chunping Jiang, Xitai Sun, Fang-gui Xu, Yue Zhang, Yitao Ding (2012)
Efficacy and safety of liver transplantation in patients with cholangiocarcinoma: A systematic review and meta‐analysisInternational Journal of Cancer, 130
D. Samuel, M. Charlton, E. Gane, Richard Brown, M. Curry, P. Kwo, R. Fontana, R. Gilroy, L. Teperman, A. Muir, J. McHutchison, W. Symonds, J. Denning, L. Mcnair, S. Arterburn, N. Terrault, X. Forns, M. Manns (2014)
P1232 SOFOSBUVIR AND RIBAVIRIN FOR THE TREATMENT OF RECURRENT HEPATITIS C INFECTION AFTER LIVER TRANSPLANTATION: RESULTS OF A PROSPECTIVE, MULTICENTER STUDYJournal of Hepatology, 60
B. Haber, J. Erlichman, K. Loomes (2008)
Recent advances in biliary atresia: prospects for novel therapiesExpert Opinion on Investigational Drugs, 17
D. Samuel, Rainer Muller, G. Alexander, L. Fassati, B. Ducot, J. Benhamou, H. Bismuth (1993)
Liver transplantation in European patients with the hepatitis B surface antigen.The New England journal of medicine, 329 25
R. Poupon, K. Lindor, K. Cauch‐Dudek, E. Dickson, R. Poupon, E. Heathcote (1997)
Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis.Gastroenterology, 113 3
Jarone Lee, A. Belanger, J. Doucette, C. Stanca, S. Friedman, N. Bach (2007)
Transplantation trends in primary biliary cirrhosis.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 5 11
P. Kamath, R. Wiesner, M. Malinchoc, W. Kremers, T. Therneau, Catherine Kosberg, G. D’Amico, E. Dickson, W. Kim (2001)
A model to predict survival in patients with end‐stage liver diseaseHepatology, 33
M. Schwartz, S. Roayaie, M. Konstadoulakis, I. Gomatos, C. Miller (2008)
The Mount Sinai experience with orthotopic liver transplantation for benign tumors: brief report and literature review: case reports.Transplantation proceedings, 40 5
Laurent Kerckhove, M. Meyer, C. Verbaandert, M. Mourad, E. Sokal, P. Goffette, A. Geubel, V. Karam, R. Adam, J. Lerut (2006)
The place of liver transplantation in Caroli's disease and syndromeTransplant International, 19
V. Wong, C. Liu (2014)
Commentary: treatment of hepatitis C‐related cirrhosis in the era of direct‐acting anti‐viralsAlimentary Pharmacology & Therapeutics, 39
L. Lindström, K. Boberg, Ola Wikman, I. Friis-Liby, R. Hultcrantz, H. Prytz, H. Sandberg-Gertzén, P. Sangfelt, A. Rydning, G. Folvik, M. Gangsøy-Kristiansen, Åke Danielsson, A. Bergquist (2012)
High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasiaAlimentary Pharmacology & Therapeutics, 35
R. Adam, P. Mcmaster, J. O'grady, D. Castaing, J. Klempnauer, N. Jamieson, P. Neuhaus, J. Lerut, M. Salizzoni, S. Pollard, F. Muhlbacher, X. Rogiers, J. Valdecasas, J. Berenguer, D. Jaeck, E. González (2003)
Evolution of liver transplantation in Europe: Report of the European Liver Transplant RegistryLiver Transplantation, 9
T. Todani, Y. Watanabe, M. Narusue, K. Tabuchi, K. Okajima (1977)
Congenital bile duct cysts: Classification, operative procedures, and review of thirty-seven cases including cancer arising from choledochal cyst.American journal of surgery, 134 2
K. Olthoff, R. Merion, R. Ghobrial, M. Abecassis, J. Fair, R. Fisher, C. Freise, I. Kam, T. Pruett, J. Everhart, T. Hulbert-Shearon, B. Gillespie, J. Emond (2005)
Outcomes of 385 Adult-to-Adult Living Donor Liver Transplant Recipients: A Report From the A2ALL ConsortiumAnnals of Surgery, 242
E. Cholongitas, J. Goulis, E. Akriviadis, G. Papatheodoridis (2011)
Hepatitis B immunoglobulin and/or nucleos(t)ide analogues for prophylaxis against hepatitis b virus recurrence after liver transplantation: A systematic reviewLiver Transplantation, 17
A. Cucchetti, G. Ercolani, M. Vivarelli, M. Cescon, M. Ravaioli, G. Ramacciato, G. Grazi, A. Pinna (2009)
Is Portal Hypertension a Contraindication to Hepatic Resection?Annals of Surgery, 250
P. Clavien, M. Lesurtel, P. Bossuyt, G. Gores, B. Langer, A. Perrier (2012)
Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report.The Lancet. Oncology, 13 1
T. Ikegami, T. Yoshizumi, K. Shirabe, Y. Maehara (2014)
Frequent plasma cell hepatitis during telaprevir-based triple therapy for hepatitis C after liver transplantation.Journal of hepatology, 60 4
J. Fléjou, J. Barge, Yves Menu, Claude Degott, Henri Bismuth, François Potet, J. Benhamou (1985)
Liver adenomatosis. An entity distinct from liver adenoma?Gastroenterology, 89 5
Y. Treut, Emilie Gregoire, Jacques Belghiti, O. Boillot, O. Soubrane, Georges Mantion, D. Cherqui, D. Castaing, Philippe Ruszniewski, Philippe Wolf, François Paye, Ephrem Salamé, Fabrice Muscari, F. Pruvot, J. Baulieux (2008)
Predictors of Long‐Term Survival After Liver Transplantation for Metastatic Endocrine Tumors: An 85‐Case French Multicentric ReportAmerican Journal of Transplantation, 8
R. Fisher, L. Kulik, C. Freise, A. Lok, T. Shearon, Robert Brown, R. Ghobrial, J. Fair, K. Olthoff, I. Kam, C. Berg (2007)
Hepatocellular Carcinoma Recurrence and Death Following Living and Deceased Donor Liver TransplantationAmerican Journal of Transplantation, 7
M. Coto-Llerena, S. Pérez‐del‐Pulgar, G. Crespo, J. Carrión, S. Martínez, J. Sánchez‐Tapias, J. Martorell., M. Navasa, X. Forns (2011)
Donor and Recipient IL28B Polymorphisms in HCV‐Infected Patients Undergoing Antiviral Therapy before and after Liver TransplantationAmerican Journal of Transplantation, 11
Dave Jones, N. Bhala, Jennifer Burt, J. Goldblatt, M. Prince, J. Newton, Prof David, EJ Jones (2005)
Four year follow up of fatigue in a geographically defined primary biliary cirrhosis patient cohortGut, 55
R. Vukotic, M. Morelli, A. Pinna, M. Margotti, F. Foschi, E. Loggi, M. Bernardi, P. Andreone (2014)
Letter: calcineurin inhibitor level reduction during treatment with sofosbuvir in liver transplanted patientsAlimentary Pharmacology & Therapeutics, 40
A. Coilly, V. Furlan, B. Roche, C. Barau, Coralie Noël, L. Bonhomme‐Faivre, T. Antonini, A. Roque-Afonso, D. Samuel, A. Taburet, J. Duclos‐Vallée (2012)
Practical Management of Boceprevir and Immunosuppressive Therapy in Liver Transplant Recipients with Hepatitis C Virus RecurrenceAntimicrobial Agents and Chemotherapy, 56
C. Werner, Daniel Egetemeyr, U. Lauer, S. Nadalin, A. Königsrainer, N. Malek, C. Berg (2012)
Telaprevir‐based triple therapy in liver transplant patients with hepatitis C virus: A 12‐week pilot study providing safety and efficacy dataLiver Transplantation, 18
Y. Liaw, M. Raptopoulou‐Gigi, H. Cheinquer, S. Sarin, T. Tanwandee, N. Leung, C. Peng, R. Myers, Robert Brown, L. Jeffers, N. Tsai, J. Białkowska, Shijie Tang, S. Beebe, E. Cooney (2011)
Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized, open‐label studyHepatology, 54
M. Berenguer, A. Palau, V. Aguilera, J. Rayón, F. Juan, M. Prieto (2008)
Clinical Benefits of Antiviral Therapy in Patients with Recurrent Hepatitis C Following Liver TransplantationAmerican Journal of Transplantation, 8
M. García-Retortillo, X. Forns, A. Feliu, E. Moitinho, Josep Costa, M. Navasa, A. Rimola, J. Rodés (2002)
Hepatitis C virus kinetics during and immediately after liver transplantationHepatology, 35
I. Murray-Lyon, R. Stern, Roger Williams (1973)
Controlled trial of prednisone and azathioprine in active chronic hepatitis.Lancet, 1 7806
K. Vakili, J. Pomposelli, Y. Cheah, M. Akoad, W. Lewis, U. Khettry, F. Gordon, K. Khwaja, R. Jenkins, E. Pomfret (2009)
Living donor liver transplantation for hepatocellular carcinoma: Increased recurrence but improved survivalLiver Transplantation, 15
(2012)
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.Journal of hepatology, 56 4
R. Pichlmayr, A. Weimann, J. Klempnauer, K. Oldhafer, H. Maschek, G. Tusch, B. Ringe (1996)
Surgical treatment in proximal bile duct cancer. A single-center experience.Annals of surgery, 224 5
K. Jørgensen, L. Lindström, M. Cvancarova, M. Castedal, S. Friman, E. Schrumpf, A. Foss, H. Isoniemi, A. Nordin, K. Holte, A. Rasmussen, A. Bergquist, M. Vatn, K. Boberg (2012)
Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter studyScandinavian Journal of Gastroenterology, 47
M. Ravaioli, G. Ercolani, F. Neri, M. Cescon, Giacomo Stacchini, M. Gaudio, A. Cucchetti, A. Pinna (2014)
Liver transplantation for hepatic tumors: a systematic review.World journal of gastroenterology, 20 18
M. Cescon, A. Cucchetti, M. Ravaioli, A. Pinna (2013)
Hepatocellular carcinoma locoregional therapies for patients in the waiting list. Impact on transplantability and recurrence rate.Journal of hepatology, 58 3
J. Dimick, John Cowan, J. Knol, G. Upchurch (2003)
Hepatic resection in the United States: indications, outcomes, and hospital procedural volumes from a nationally representative database.Archives of surgery, 138 2
T. Fukuhara, A. Taketomi, T. Motomura, S. Okano, A. Ninomiya, T. Abe, H. Uchiyama, Y. Soejima, K. Shirabe, Y. Matsuura, Y. Maehara (2010)
Variants in IL28B in liver recipients and donors correlate with response to peg-interferon and ribavirin therapy for recurrent hepatitis C.Gastroenterology, 139 5
G. MacQuillan, M. Seyam, P. Nightingale, J. Neuberger, N. Murphy (2005)
Blood lactate but not serum phosphate levels can predict patient outcome in fulminant hepatic failureLiver Transplantation, 11
S. Cho, J. Marsh, J. Steel, S. Holloway, J. Heckman, E. Ochoa, D. Geller, T. Gamblin (2008)
Surgical Management of Hepatocellular Adenoma: Take It or Leave It?Annals of Surgical Oncology, 15
J. Fung, Cindy Cheung, See-Ching Chan, M. Yuen, K. Chok, W. Sharr, W. Dai, A. Chan, T. Cheung, Simon Tsang, B. Lam, Ching‐lung Lai, C. Lo (2011)
Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation.Gastroenterology, 141 4
Sung‐Gyu Lee, G. Song, Shin Hwang, T. Ha, D. Moon, D. Jung, Ki Kim, C. Ahn, Myung-Hwan Kim, Sung‐Koo Lee, K. Sung, G. Ko (2010)
Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experienceJournal of Hepato-Biliary-Pancreatic Sciences, 17
A. Dhawan, R. Taylor, P. Cheeseman, P. Silva, L. Katsiyiannakis, G. Mieli-Vergani (2005)
Wilson's disease in children: 37‐Year experience and revised King's score for liver transplantationLiver Transplantation, 11
J. Llovet, C. Brú, J. Bruix (1999)
Prognosis of Hepatocellular Carcinoma: The BCLC Staging ClassificationSeminars in Liver Disease, 19
S. Bresson-Hadni, S. Koch, J. Miguet, M. Gillet, G. Mantion, B. Heyd, D. Vuitton, A. clinicians (2003)
Indications and results of liver transplantation for Echinococcus alveolar infection: an overviewLangenbeck's Archives of Surgery, 388
I. Lenci, G. Tisone, D. Paolo, F. Marcuccilli, L. Tariciotti, M. Ciotti, V. Svicher, C. Perno, M. Angelico (2011)
Safety of complete and sustained prophylaxis withdrawal in patients liver-transplanted for HBV-related cirrhosis at low risk of HBV recurrence.Journal of hepatology, 55 3
M. Berenguer (2008)
Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin.Journal of hepatology, 49 2
Y. Liaw, I. Sheen, Chuan‐Mo Lee, U. Akarca, G. Papatheodoridis, Florence Wong, Ting Chang, A. Horban, Chia Wang, P. Kwan, M. Buti, M. Prieto, T. Berg, K. Kitrinos, Kenneth Peschell, E. Mondou, David Frederick, F. Rousseau, E. Schiff (2011)
Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver diseaseHepatology, 53
Reeta Veteläinen, D. Erdogan, W. Graaf, F. Kate, P. Jansen, D. Gouma, T. Gulik (2008)
Liver adenomatosis: re‐evaluation of aetiology and managementLiver International, 28
V. Mazzaferro, J. Llovet, R. Miceli, S. Bhoori, M. Schiavo, L. Mariani, T. Camerini, S. Roayaie, M. Schwartz, G. Grazi, R. Adam, P. Neuhaus, M. Salizzoni, J. Bruix, A. Forner, L. Carlis, U. Cillo, A. Burroughs, R. Troisi, M. Rossi, G. Gerunda, J. Lerut, J. Belghiti, I. Boin, J. Gugenheim, F. Rochling, B. Hoek, P. Majno (2009)
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis.The Lancet. Oncology, 10 1
M. Hagness, A. Foss, P. Line, T. Scholz, P. Jørgensen, B. Fosby, K. Boberg, Ø. Mathisen, I. Gladhaug, T. Egge, S. Solberg, J. Hausken, S. Dueland (2013)
Liver Transplantation for Nonresectable Liver Metastases From Colorectal CancerAnnals of Surgery, 257
Ilja Vreede, J. Steers, P. Burch, C. Rosen, L. Gunderson, M. Haddock, L. Burgart, G. Gores (2000)
Prolonged disease‐free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinomaLiver Transplantation, 6
E. Schiff, Ching‐lung Lai, S. Hadziyannis, P. Neuhaus, N. Terrault, M. Colombo, H. Tillmann, D. Samuel, S. Zeuzem, J. Villeneuve, S. Arterburn, K. Borroto-Esoda, C. Brosgart, S. Chuck (2007)
Adefovir dipivoxil for wait‐listed and post–liver transplantation patients with lamivudine‐resistant hepatitis B: Final long‐term resultsLiver Transplantation, 13
R. Cruz, S. Ranganathan, G. Mazariegos, K. Soltys, Navdeep Nayyar, Qing Sun, G. Bond, Peter Shaw, Kimberly Haberman, L. Krishnamurti, J. Marsh, A. Humar, R. Sindhi (2013)
Analysis of national and single-center incidence and survival after liver transplantation for hepatoblastoma: new trends and future opportunities.Surgery, 153 2
S. Zeuzem, P. Andreone, S. Pol, E. Lawitz, M. Diago, S. Roberts, R. Focaccia, Z. Younossi, G. Foster, A. Horban, P. Ferenci, F. Nevens, B. Müllhaupt, P. Pockros, R. Terg, D. Shouval, B. Hoek, O. Weiland, R. Heeswijk, S. Meyer, D. Luo, G. Boogaerts, R. Polo, G. Picchio, M. Beumont (2011)
Telaprevir for retreatment of HCV infection.The New England journal of medicine, 364 25
A. Cucchetti, A. Vitale, M. Gaudio, M. Ravaioli, G. Ercolani, M. Cescon, M. Zanello, M. Morelli, U. Cillo, G. Grazi, A. Pinna (2010)
Harm and Benefits of Primary Liver Resection and Salvage Transplantation for Hepatocellular CarcinomaAmerican Journal of Transplantation, 10
D. Sudan, A. Deroover, S. Chinnakotla, I. Fox, B. Shaw, T. Mccashland, M. Sorrell, M. Tempero, A. Langnas (2002)
Radiochemotherapy and Transplantation Allow Long‐Term Survival For Nonresectable Hilar CholangiocarcinomaAmerican Journal of Transplantation, 2
T. Aoba, T. Ebata, Y. Yokoyama, T. Igami, G. Sugawara, Y. Takahashi, Y. Nimura, M. Nagino (2013)
Assessment of Nodal Status for Perihilar Cholangiocarcinoma: Location, Number, or Ratio of Involved NodesAnnals of Surgery, 257
N. Terrault, M. Berenguer (2006)
Treating hepatitis C infection in liver transplant recipientsLiver Transplantation, 12
S. Habib, O. Shakil, O. Couto, A. Demetris, J. Fung, A. Marcos, K. Chopra (2006)
Caroli's disease and orthotopic liver transplantationLiver Transplantation, 12
V. Mazzaferro, A. Pulvirenti, J. Coppa (2007)
Neuroendocrine tumors metastatic to the liver: how to select patients for liver transplantation?Journal of hepatology, 47 4
T. Ueno, Y. Barri, G. Netto, Adrian Martin, N. Onaca, E. Sanchez, S. Chinnakotla, H. Randall, S. Dawson, M. Levy, R. Goldstein, G. Klintmalm (2006)
Liver and Kidney Transplantation for Polycystic Liver and Kidney-Renal Function and OutcomeTransplantation, 82
Rohit Loomba, Rohit Loomba, Ayana Rowley, R. Wesley, Karen Smith, T. Liang, F. Pucino, G. Csako (2008)
Hepatitis B immunoglobulin and Lamivudine improve hepatitis B-related outcomes after liver transplantation: meta-analysis.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 6 6
W. Rao, Xue-jie Wu, D. Xiu (2009)
Lamivudine or lamivudine combined with hepatitis B immunoglobulin in prophylaxis of hepatitis B recurrence after liver transplantation: a meta‐analysisTransplant International, 22
G. Gores, D. Nagorney, C. Rosen (2007)
Cholangiocarcinoma: is transplantation an option? For whom?Journal of hepatology, 47 4
E. Grossman, J. Millis (2010)
Liver transplantation for non–hepatocellular carcinoma malignancy: Indications, limitations, and analysis of the current literatureLiver Transplantation, 16
G. Cavallari, B. Nardo, R. Montalti, P. Beltempo, R. Bertelli, L. Puviani, A. Faenza, A. Cavallari (2004)
Combined liver-kidney transplantation: experience at Bologna's transplant center.Transplantation proceedings, 36 3
M. Berenguer, M. Prieto, J. Rayón, J. Mora, M. Pastor, V. Ortiz, D. Carrasco, F. Juan, M. Burgueño, J. Mir, J. Berenguer (2000)
Natural history of clinically compensated hepatitis C virus–related graft cirrhosis after liver transplantationHepatology, 32
F. Yao, L. Ferrell, N. Bass, J. Watson, P. Bacchetti, A. Venook, N. Ascher, J. Roberts (2001)
Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survivalHepatology, 33
U. Cillo, A. Vitale, M. Bassanello, P. Boccagni, A. Brolese, G. Zanus, P. Burra, S. Fagiuoli, F. Farinati, M. Rugge, D. D’amico (2004)
Liver Transplantation for the Treatment of Moderately or Well-Differentiated Hepatocellular CarcinomaAnnals of Surgery, 239
V. Saxena, A. Monto, N. Terrault (2014)
Commentary: treatment of hepatitis C‐related cirrhosis in the era of direct‐acting anti‐virals – authors’ replyAlimentary Pharmacology & Therapeutics, 39
G. Locke, T. Therneau, J. Ludwig, E. Dickson, K. Lindor (1996)
Time course of histological progression in primary biliary cirrhosisHepatology, 23
J. Hernandez, Carlos Alfonso, L. González, M. Samada, L. Ramos, M. Cepero-Valdez, A. Abdo, F. Gómez, R. Castellanos, O. López, J. Ugarte, J. Jordán (2006)
Solid mesenchymal hamartoma in an adult: a case reportJournal of Clinical Pathology, 59
A. Mehrabi, A. Kashfi, H. Fonouni, P. Schemmer, B. Schmied, P. Hallscheidt, P. Schirmacher, J. Weitz, H. Friess, M. Bũchler, Jan Schmidt (2006)
Primary malignant hepatic epithelioid hemangioendotheliomaCancer, 107
C. Corpechot, A. Poujol-Robert, D. Wendum, M. Galotte, Y. Chrétien, R. Poupon, R. Poupon (2004)
Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA‐treated patients with primary biliary cirrhosisLiver International, 24
J. O'grady, Heather Smith, S. Davies, H. Daniels, P. Donaldson, K. Tan, B. Portmann, G. Alexander, Roger Williams (1992)
Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications.Journal of hepatology, 14 1
J. Roll, J. Boyer, D. Barry, G. Klatskin (1983)
The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis.The New England journal of medicine, 308 1
R. Koff (2014)
Review article: the efficacy and safety of sofosbuvir, a novel, oral nucleotide NS5B polymerase inhibitor, in the treatment of chronic hepatitis C virus infectionAlimentary Pharmacology & Therapeutics, 39
S. Dokmak, V. Paradis, V. Vilgrain, A. Sauvanet, O. Farges, D. Valla, P. Bedossa, J. Belghiti (2009)
A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas.Gastroenterology, 137 5
J. O'grady, G. Alexander, K. Hayllar, Roger Williams (1989)
Early indicators of prognosis in fulminant hepatic failure.Gastroenterology, 97 2
T. Starzl (2002)
The saga of liver replacement, with particular reference to the reciprocal influence of liver and kidney transplantation (1955-1967).Journal of the American College of Surgeons, 195 5
M. Lucey, M. Lucey, D. Graham, D. Graham, P. Martin, P. Martin, A. Bisceglie, A. Bisceglie, S. Rosenthal, S. Rosenthal, J. Waggoner, J. Waggoner, R. Merion, D. Campbell, T. Nostrant, T. Nostrant, H. Appelman, H. Appelman (1992)
Recurrence of hepatitis B and delta hepatitis after orthotopic liver transplantation.Gut, 33
K. Boberg, E. Aadland, J. Jahnsen, N. Raknerud, M. Stiris, H. Bell (1998)
Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population.Scandinavian journal of gastroenterology, 33 1
L. Rosenberg (1991)
The risk of liver neoplasia in relation to combined oral contraceptive use.Contraception, 43 6
M. Angelico, D. Paolo, M. Trinito, A. Petrolati, A. Araco, S. Zazza, R. Lionetti, C. Casciani, G. Tisone (2001)
Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV‐related cirrhosisHepatology, 35
Marcella Urego, J. Flickinger, B. Carr (1999)
Radiotherapy and multimodality management of cholangiocarcinoma.International journal of radiation oncology, biology, physics, 44 1
R. Poupon, O. Chazouilleres, B. Balkau, R. Poupon (1999)
Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosisJournal of Hepatology, 30
K. Boonstra, U. Beuers, C. Ponsioen (2012)
Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review.Journal of hepatology, 56 5
C. Lange, D. Moradpour, Alexandra Doehring, H. Lehr, B. Müllhaupt, S. Bibert, P. Bochud, A. Antonino, M. Pascual, H. Farnik, Ying Shi, W. Bechstein, C. Moench, M. Hansmann, C. Sarrazin, J. Lötsch, S. Zeuzem, W. Hofmann (2011)
Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection.Journal of hepatology, 55 2
B. Bailey, D. Amre, P. Gaudreault (2003)
Fulminant hepatic failure secondary to acetaminophen poisoning: A systematic review and meta-analysis of prognostic criteria determining the need for liver transplantationCritical Care Medicine, 31
N. Mulder, J. Elema, P. Postmus (1989)
TRANSFUSION ASSOCIATED GRAFT-VERSUS-HOST DISEASE IN AUTOLOGOUS BONE MARROW TRANSPLANTATIONThe Lancet, 333
Ricardo Drut, R. Drut, Gómez Ma, E. Rúa, María Lojo (1998)
Presence of human papillomavirus in extrahepatic biliary atresia.Journal of pediatric gastroenterology and nutrition, 27 5
C. Lange, J. Bojunga, W. Hofmann, Katrin Wunder, U. Mihm, S. Zeuzem, C. Sarrazin (2009)
Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver functionHepatology, 50
V. Mazzaferro, E. Regalia, R. Doci, S. Andreola, A. Pulvirenti, F. Bozzetti, F. Montalto, M. Ammatuna, A. Morabito, L. Gennari (1996)
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.The New England journal of medicine, 334 11
Paulette 5, Hervé Laumonier2, Christophe Laurent3, Jean 5, Charles 5 (2008)
Benign and Malignant Vascular Tumors of the Liver in AdultsSemin Liver Dis, 28
U. Beuers, K. Boberg, R. Chapman, O. Chazouilleres, P. Invernizzi, D. Jones, F. Lammert, A. Parés, M. Trauner (2009)
EASL Clinical Practice Guidelines: management of cholestatic liver diseases.Journal of hepatology, 51 2
I. Jacobson, J. McHutchison, G. Dusheiko, A. Bisceglie, K. Reddy, N. Bzowej, P. Marcellin, A. Muir, P. Ferenci, R. Flisiak, J. George, M. Rizzetto, D. Shouval, R. Solá, R. Terg, E. Yoshida, N. Adda, L. Bengtsson, A. Sankoh, Tara Kieffer, S. George, R. Kauffman, S. Zeuzem, V. Phar (2011)
Telaprevir for previously untreated chronic hepatitis C virus infection.The New England journal of medicine, 364 25
E. Cholongitas, G. Papatheodoridis, A. Burroughs (2010)
Liver grafts from anti-hepatitis B core positive donors: a systematic review.Journal of hepatology, 52 2
E. Gane, C. Stedman, R. Hyland, Xiao Ding, E. Svarovskaia, W. Symonds, R. Hindes, M. Berrey (2013)
Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C.The New England journal of medicine, 368 1
Rana Domiati, Saad, D., Brian Dawson, Linda, R., Margraf, Milton, J., Finegold, Arthur, G., Weinberg, B. Rogers (2000)
Cytomegalovirus and Human Herpesvirus 6, but Not Human Papillomavirus, Are Present in Neonatal Giant Cell Hepatitis and Extrahepatic Biliary AtresiaPediatric and Developmental Pathology, 3
K. Schütte, J. Bornschein, P. Malfertheiner (2009)
Hepatocellular Carcinoma – Epidemiological Trends and Risk FactorsDigestive Diseases, 27
B. Roche, D. Samuel (2011)
Is early antiviral therapy for recurrent hepatitis C after liver transplantation superior to later treatment? The answer is noLiver Transplantation, 17
B. Veldt, J. Poterucha, K. Watt, R. Wiesner, J. Hay, W. Kremers, C. Rosen, J. Heimbach, M. Charlton (2008)
Impact of Pegylated Interferon and Ribavirin Treatment on Graft Survival in Liver Transplant Patients with Recurrent Hepatitis C InfectionAmerican Journal of Transplantation, 8
J. Ferlay, I. Soerjomataram, M. Ervik, R. Dikshit, S. Eser, C. Mathers (2013)
GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer
[The list of indications for liver transplantation (LT) includes irreversible causes of end-stage liver disease which are curable by the procedure. More than a decade ago, the American Association for the Study of the Liver Disease (AASLD) established minimal listing criteria for patients with end-stage liver disease. To qualify for waiting list, the 1 year expected survival should be <90 % without LT. Liver transplantation should lead to prolonged survival and/or an improved quality of life [10]. Indications can be segregated into two classes: (1) acute conditions leading to a rapid and irreversible liver failure and (2) chronic diseases that can lead to liver failure and/or complications of end-stage liver disease. In the present introduction, causes of acute liver failure were discussed, whereas in the following chapters, each indication for LT was reported and analyzed.]
Published: Mar 6, 2015
Keywords: Liver Transplantation; Sustained Virological Response; Primary Biliary Cirrhosis; Primary Sclerosing Cholangitis; Biliary Atresia
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.